title: [Does the use of psychoactive drugs in adolescence create specific problems?].
abstract: The use of psychoactive drugs by teenagers presents commonalities and specificities depending on the substances used. The connection noted between the early age of use and the onset of harm, supports the recommendation of early interventions targeting all drugs. However, drug use differs according to the type of substance, highlighting the need to take into accountthese specificities in addiction therapy.
authors.affiliation: Consultation Jeunes Consommateurs-CSAPA Boucebci, UF Addictologie Spécialisée-Service de psychopathologie, APHP, Hôpital Avicenne, 125 rue de Stalingrad, 93000 Bobigny, France.
authors.forename: Raphaël
authors.initials: R
authors.lastname: Jeannin
authors.affiliation: Consultation Jeunes Consommateurs-CSAPA Boucebci, UF Addictologie Spécialisée-Service de psychopathologie, APHP, Hôpital Avicenne, 125 rue de Stalingrad, 93000 Bobigny, France.
authors.forename: Aymeric
authors.initials: A
authors.lastname: Reyre
authors.affiliation: Maison des adolescents Casita, service de psychopathologie de l'enfant et de l'adolescent, Hôpital Avicenne, APHP, 93000 Bobigny, France.
authors.forename: Christophe
authors.initials: C
authors.lastname: Philippe
authors.affiliation: Service d'addictologie, Hôpital René-Muret, APHP, 93270 Sevran, France.
authors.forename: Anne
authors.initials: A
authors.lastname: Borgne
authors.affiliation: Hôpital de la Pitié-Salpêtrière, 75013 Paris, France.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Bonnet
authors.affiliation: CSAPA Espace Murger, service de psychiatrie, Hôpital Fernand-Widal, APHP, 75010 Paris, France.
authors.forename: Louis
authors.initials: L
authors.lastname: Bacconi
authors.affiliation: CSAPA Espace Murger, service de psychiatrie, Hôpital Fernand-Widal, APHP, 75010 Paris, France.
authors.forename: Gaël
authors.initials: G
authors.lastname: Dupuy
mesh_terms: D000293:Adolescent; D000294:Adolescent Behavior; D000428:Alcohol Drinking / Q000009:adverse effects*; D006801:Humans; D011619:Psychotropic Drugs / Q000009:adverse effects*; D019966:Substance-Related Disorders / Q000150:complications*
chemical_list: D011619:Psychotropic Drugs